Japanese Pediatric Leukemia/Lymphoma Study Group Prospective observational study of relapsed/refractory pediatric acute myeloid leukemia
Not Applicable
Recruiting
- Conditions
- Relapsed/refractory acute myeloid leukemia
- Registration Number
- JPRN-UMIN000031734
- Lead Sponsor
- Japanese Pediatric Leukemia/Lymphoma Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
Additional or multiple relapsed patients Patients with secondary acute myeloid leukemia
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-year overall, event-free, and progression-free survival after diagnosis of relapsed/refractory acute myeloid leukemia 3-year overall, event-free, and progression-free survival after hematopoietic stem cell transplantation
- Secondary Outcome Measures
Name Time Method